Cargando…

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) displays a typical mucin expression pattern which is characterized by MUC1 positive, MUC2 negative, and MUC5AC positive. More and more evidences show that mucins are involved in the development of pancreatic diseases. However, the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yunzhen, Gong, Yitao, Liu, Yu, Chen, Yusheng, Wang, Ruijie, Dai, Zhengjie, Zou, Xuan, Tasiheng, Yesiboli, Luo, Guopei, Lin, Xuan, Wang, Xu, Cheng, He, Yu, Xianjun, Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334048/
https://www.ncbi.nlm.nih.gov/pubmed/35910854
http://dx.doi.org/10.1155/2022/7353572
_version_ 1784759013710233600
author Qian, Yunzhen
Gong, Yitao
Liu, Yu
Chen, Yusheng
Wang, Ruijie
Dai, Zhengjie
Zou, Xuan
Tasiheng, Yesiboli
Luo, Guopei
Lin, Xuan
Wang, Xu
Cheng, He
Yu, Xianjun
Liu, Chen
author_facet Qian, Yunzhen
Gong, Yitao
Liu, Yu
Chen, Yusheng
Wang, Ruijie
Dai, Zhengjie
Zou, Xuan
Tasiheng, Yesiboli
Luo, Guopei
Lin, Xuan
Wang, Xu
Cheng, He
Yu, Xianjun
Liu, Chen
author_sort Qian, Yunzhen
collection PubMed
description BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) displays a typical mucin expression pattern which is characterized by MUC1 positive, MUC2 negative, and MUC5AC positive. More and more evidences show that mucins are involved in the development of pancreatic diseases. However, the relationship between mucin expression and prognosis of PDAC patients has been controversial in the past decades; therefore, we aim to figure out the association of mucin expression with survival in PDAC patients who underwent radical resection. METHODS: We performed immunohistochemistry (IHC) to detect the expression of MUC1, MUC2, and MUC5AC in resected PDAC specimens from Shanghai Cancer Center, Fudan University (FUSCC, n = 427) and obtained the corresponding clinical statistical data for retrospective study. Kaplan-Meier methods and Mantel-Cox tests were used to compare the survival curves, and the Cox regression model was employed for multivariate analyses to determine the independent risk factors. Survival analysis was also performed in the Queensland Centre for Medical Genomics (QCMG, n = 70) PDAC cohort to verify the conclusion. RESULTS: Both the FUSCC cohort and the QCMG cohort demonstrated that MUC1 absence was significantly correlated with worse overall survival (OS). The presence of MUC2 showed marginal significance in predicting shorter OS of PDAC patients, while MUC5AC had no prognostic value. In the FUSCC cohort, MUC1 absence was associated with increased proportion of stage III PDAC (p = 0.011), and MUC1 absence and MUC2 presence were associated with tumour perineural aggression (p = 0.011 and p = 0.030, respectively). Multivariable adjusted hazard ratios (HRs) for mortality of MUC1 and MUC2 were 0.492 (95% CI: 0.274-0.883, p = 0.017) and 1.596 (95% CI: 1.061-2.401, p = 0.025), respectively. CONCLUSIONS: MUC1 absence or MUC2 presence is independently associated with poor OS among patients with resectable PDAC. MUC5AC absence tended to be associated with short-term death.
format Online
Article
Text
id pubmed-9334048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93340482022-07-29 Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma Qian, Yunzhen Gong, Yitao Liu, Yu Chen, Yusheng Wang, Ruijie Dai, Zhengjie Zou, Xuan Tasiheng, Yesiboli Luo, Guopei Lin, Xuan Wang, Xu Cheng, He Yu, Xianjun Liu, Chen J Immunol Res Research Article BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) displays a typical mucin expression pattern which is characterized by MUC1 positive, MUC2 negative, and MUC5AC positive. More and more evidences show that mucins are involved in the development of pancreatic diseases. However, the relationship between mucin expression and prognosis of PDAC patients has been controversial in the past decades; therefore, we aim to figure out the association of mucin expression with survival in PDAC patients who underwent radical resection. METHODS: We performed immunohistochemistry (IHC) to detect the expression of MUC1, MUC2, and MUC5AC in resected PDAC specimens from Shanghai Cancer Center, Fudan University (FUSCC, n = 427) and obtained the corresponding clinical statistical data for retrospective study. Kaplan-Meier methods and Mantel-Cox tests were used to compare the survival curves, and the Cox regression model was employed for multivariate analyses to determine the independent risk factors. Survival analysis was also performed in the Queensland Centre for Medical Genomics (QCMG, n = 70) PDAC cohort to verify the conclusion. RESULTS: Both the FUSCC cohort and the QCMG cohort demonstrated that MUC1 absence was significantly correlated with worse overall survival (OS). The presence of MUC2 showed marginal significance in predicting shorter OS of PDAC patients, while MUC5AC had no prognostic value. In the FUSCC cohort, MUC1 absence was associated with increased proportion of stage III PDAC (p = 0.011), and MUC1 absence and MUC2 presence were associated with tumour perineural aggression (p = 0.011 and p = 0.030, respectively). Multivariable adjusted hazard ratios (HRs) for mortality of MUC1 and MUC2 were 0.492 (95% CI: 0.274-0.883, p = 0.017) and 1.596 (95% CI: 1.061-2.401, p = 0.025), respectively. CONCLUSIONS: MUC1 absence or MUC2 presence is independently associated with poor OS among patients with resectable PDAC. MUC5AC absence tended to be associated with short-term death. Hindawi 2022-07-21 /pmc/articles/PMC9334048/ /pubmed/35910854 http://dx.doi.org/10.1155/2022/7353572 Text en Copyright © 2022 Yunzhen Qian et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Qian, Yunzhen
Gong, Yitao
Liu, Yu
Chen, Yusheng
Wang, Ruijie
Dai, Zhengjie
Zou, Xuan
Tasiheng, Yesiboli
Luo, Guopei
Lin, Xuan
Wang, Xu
Cheng, He
Yu, Xianjun
Liu, Chen
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
title Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
title_full Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
title_fullStr Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
title_short Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
title_sort atypical mucin expression predicts worse overall survival in resectable pancreatic ductal adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334048/
https://www.ncbi.nlm.nih.gov/pubmed/35910854
http://dx.doi.org/10.1155/2022/7353572
work_keys_str_mv AT qianyunzhen atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT gongyitao atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT liuyu atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT chenyusheng atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT wangruijie atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT daizhengjie atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT zouxuan atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT tasihengyesiboli atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT luoguopei atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT linxuan atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT wangxu atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT chenghe atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT yuxianjun atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma
AT liuchen atypicalmucinexpressionpredictsworseoverallsurvivalinresectablepancreaticductaladenocarcinoma